CELEX: 32022M10585
Language: en
Date: 2022-01-20 00:00:00
Title: Commission Decision of 20/01/2022 declaring a concentration to be compatible with the common market (Case No COMP/M.10585 - APMH INVEST / UNILABS) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                 Brussels, 20.1.2022
                                                                 C(2022) 430 final
                                                                                 PUBLIC VERSION
                                                                 APMH Invest A/S
                                                                 Esplanaden 50
                                                                 1263 Copenhagen K
                                                                 Denmark
Subject:        Case M.10585 – APMH INVEST / UNILABS
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                       1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 17 December 2021, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which APMH Invest
        A/S (“APMHI”, Denmark) acquires within the meaning of Article 3(1)(b) of the
        Merger Regulation control of the whole of Unilabs Holding AB (“Unilabs”,
        Switzerland) by way of purchase of shares.3
2.      The business activities of the undertakings concerned are:
             for APMHI: globally active investment company controlled by A.P. Møller
              Holding A/S (Denmark), with investments in Maersk Tankers, Maersk Product
              Tankers, A.P. Moller Capital, KK Wind Solutions Holding A/S, Faerch, Nissens
              Cooling Solutions, Maersk Drilling, Danske Bank A/S and other financial
              investments in fixed income and securities. A.P. Møller Holding A/S also controls
              A.P. Møller-Mærsk A/S, an integrated transport and logistics company with
              worldwide activities,
             for Unilabs, controlled by Cidra GP S.à.r.l (Luxembourg): provider of diagnostic
              services, which is active in the provision of bio-medical testing services (also
              known as CLTS), medical imaging services, reproductive medicine services and
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 523, 28.12.2021, p. 8.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---         drug development services. Unilabs has laboratories and/or imaging centres in
        several EU- and non-EU countries.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                  For the Commission
                                                  (Signed)
                                                  Olivier GUERSENT
                                                  Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                              2